Kite Pharma, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (39)

Latest Posts

About This Stock More About This Stock
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski
Tuesday, February 6, 2018 3:12 PM EDT
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
E Ford Model T And Personalized Medicine
Article By: Ketan Desai
Monday, December 11, 2017 10:35 AM EDT
While technology marches on, the economics of personalized medicines just don’t add up. Will they be like costly trinkets being displayed in a museum that we can watch at a distance but not own?
In this article: JUNO, KITE, EDIT
Read
Best Sector ETF Of Q3 And Its Top-Performing Stocks
Article By: Sweta Killa
Monday, October 2, 2017 3:08 PM EDT
The biotech sector led the U.S. stock market higher last quarter with Virtus LifeSci Biotech Clinical Trials ETF topping the list of the best-performing ETFs, logging impressive returns of about 21.4%.
In this article: SGMO, DVAX, INSM, KITE, MYOK, BBC
Read
6 ETF Picks For September
Article By: Zacks Investment Research
Wednesday, September 6, 2017 6:44 AM EDT
The Euro zone economic growth has looked up this year. The region grew 0.6% sequentially in Q2 following 0.5% expansion in the previous period. Despite this positive sentiment, a rising euro might be a deterrent.
In this article: AOM, DFE, SMH, XBI, KITE, ACWF Also: QQQ, GILD
Read
Biopharmaceuticals Portfolio In A Biotech Bull Market
Article By: Rod Raynovich
Tuesday, September 5, 2017 11:08 PM EDT
Biotech stocks broke through the July sector highs as tracked by major ETFs. However we are still about 25% off the July 2015 bubble highs but supported by good earnings fundamentals, strong technicals and potentially a seasonal strong Q4.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, BIIB, GILD, XBI, ABBV, KITE, BLUE, FMI
Read

PARTNER HEADLINES

Latest Tweets for $KITE

No tweets yet!

$KITE

Gilead Sciences Takes First Step Towards Higher Valuation Multiple
Moon Kil Woong 8/28/2017 9:38:10 PM

I tend to look down on companies that depend on buying up others to fuel their research and growth, especially at high valuations when their own stock has a low valuation. I'd be somewhat neutral on this buyout. The real winner is $KITE and their competitors, not #Gilead.

Biotech Buzz Is Broken
Alpha Stockman 4/29/2015 7:09:10 PM

$KITE opened pretty good, $JUNO needs a bounce

1 to 2 of 2 comments